158 related articles for article (PubMed ID: 24418542)
1. Inhibition of HIV by Legalon-SIL is independent of its effect on cellular metabolism.
McClure J; Margineantu DH; Sweet IR; Polyak SJ
Virology; 2014 Jan; 449():96-103. PubMed ID: 24418542
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
McClure J; Lovelace ES; Elahi S; Maurice NJ; Wagoner J; Dragavon J; Mittler JE; Kraft Z; Stamatatos L; Horton H; De Rosa SC; Coombs RW; Polyak SJ
PLoS One; 2012; 7(7):e41832. PubMed ID: 22848626
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Silibinin A on Mitochondrial Function in Neuronal PC12 and HepG2 Liver Cells.
Esselun C; Bruns B; Hagl S; Grewal R; Eckert GP
Oxid Med Cell Longev; 2019; 2019():1652609. PubMed ID: 31871539
[TBL] [Abstract][Full Text] [Related]
4. Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
Wagoner J; Morishima C; Graf TN; Oberlies NH; Teissier E; Pécheur EI; Tavis JE; Polyak SJ
PLoS One; 2011 Jan; 6(1):e16464. PubMed ID: 21297992
[TBL] [Abstract][Full Text] [Related]
5. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
6. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
7. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
8. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
9. Milk thistle extracts inhibit the oxidation of low-density lipoprotein (LDL) and subsequent scavenger receptor-dependent monocyte adhesion.
Wallace S; Vaughn K; Stewart BW; Viswanathan T; Clausen E; Nagarajan S; Carrier DJ
J Agric Food Chem; 2008 Jun; 56(11):3966-72. PubMed ID: 18476698
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes.
Barat C; Gilbert C; Imbeault M; Tremblay MJ
Retrovirology; 2008 Mar; 5():30. PubMed ID: 18373845
[TBL] [Abstract][Full Text] [Related]
11. Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.
Chan CN; Trinité B; Levy DN
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652233
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants.
Park IW; Han C; Song X; Green LA; Wang T; Liu Y; Cen C; Song X; Yang B; Chen G; He JJ
BMC Complement Altern Med; 2009 Aug; 9():29. PubMed ID: 19656383
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.
Mercure L; Phaneuf D; Wainberg MA
Clin Diagn Lab Immunol; 1995 Mar; 2(2):192-8. PubMed ID: 7697528
[TBL] [Abstract][Full Text] [Related]
14. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
15. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells.
Gohulkumar M; Gurushankar K; Rajendra Prasad N; Krishnakumar N
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():274-82. PubMed ID: 24907761
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
18. Understanding silibinin's modes of action against HCV using viral kinetic modeling.
Guedj J; Dahari H; Pohl RT; Ferenci P; Perelson AS
J Hepatol; 2012 May; 56(5):1019-1024. PubMed ID: 22245888
[TBL] [Abstract][Full Text] [Related]
19. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress.
Camini FC; da Silva TF; da Silva Caetano CC; Almeida LT; Ferraz AC; Alves Vitoreti VM; de Mello Silva B; de Queiroz Silva S; de Magalhães JC; de Brito Magalhães CL
Antiviral Res; 2018 Oct; 158():8-12. PubMed ID: 30076863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
